Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ECOR

ECOR - ElectroCore Inc Stock Price, Fair Value and News

$6.14-0.19 (-3.00%)
Market Closed

70/100

ECOR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

70/100

ECOR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ECOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ECOR Price Action

Last 7 days

-10.4%

Last 30 days

12.5%

Last 90 days

29.3%

Trailing 12 Months

-35.7%

ECOR RSI Chart

ECOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ECOR Valuation

Market Cap

49.1M

Price/Earnings (Trailing)

-3.47

Price/Sales (Trailing)

1.65

EV/EBITDA

-2.24

Price/Free Cashflow

-6.13

ECOR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ECOR Fundamentals

ECOR Revenue

Revenue (TTM)

29.8M

Rev. Growth (Yr)

32.58%

Rev. Growth (Qtr)

17.72%

ECOR Earnings

Earnings (TTM)

-14.2M

Earnings Growth (Yr)

-36.36%

Earnings Growth (Qtr)

7.25%

ECOR Profitability

EBT Margin

-47.52%

Return on Equity

-1.3K%

Return on Assets

-66.13%

Free Cashflow Yield

-16.31%

ECOR Investor Care

Shares Dilution (1Y)

21.99%

Diluted EPS (TTM)

-1.69

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202526.5M27.7M29.8M0
202418.7M21.3M23.3M25.2M
20239.5M10.9M13.4M16.0M
20226.1M7.0M7.5M8.6M
20214.0M4.5M4.9M5.5M
20202.7M2.8M3.2M3.5M
20191.3M1.6M2.1M2.4M
2018322.5K546.0K769.5K993.0K
201700099.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About ElectroCore Inc

ECOR
electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
 CEO
 WEBSITEelectrocore.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES62

ElectroCore Inc Frequently Asked Questions

ECOR is the stock ticker symbol of ElectroCore Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of ElectroCore Inc is 49.09 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, ECOR's PE ratio (Price to Earnings) is -3.47 and Price to Sales (PS) ratio is 1.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ECOR PE ratio will change depending on the future growth rate expectations of investors.